Patients with an asymptomatic abdominal aortic aneurysm tend to be informed inconsistently and incompletely about their disorder and the treatment options open to them. A patient decision aid helps to share treatment decisions with these patients by increasing their knowledge about the disorder and treatment options open to them, without raising anxiety levels or deteriorating health outcomes. However, it does not reduce patient decisional conflict, nor does it improve satisfaction.
INTRODUCTION
Abdominal aortic aneurysm rupture carries a high mortality rate, 1 but the majority of patients remain asymptomatic and will eventually die from another disease. Therefore, the patient's risk of rupture during watchful waiting should be weighed against the benefits and risks of elective aneurysm repair. Surgeons have an ethical obligation to share these important decisions with their patients, in addition to the legal imperative to inform patients about their health. 2 This has been formulated in a recent statement on the role patients should play in healthcare decisions. 3 In daily practice, however, aneurysm patients tend to be informed inconsistently about their disorder and the available treatment options, and the amount of information given is often less than is legally required. 4 Moreover, aneurysm patients reported being unaware of their options when making the treatment decision. 5 A decision aid, used in conjunction with regular patientsurgeon communication, may address these limitations by informing and involving patients in the decision making process. 6 Decision aids typically contain information on treatment options and outcomes related to the patient's health status and explore patient preferences and values. 7 The authors had previously developed a decision aid considering elective surgery and watchful waiting for patients with an asymptomatic abdominal aortic aneurysm. 8 The aim of the current study was to evaluate whether patients recently diagnosed with an asymptomatic abdominal aortic aneurysm benefit from using this decision aid in addition to regular information from their surgeon. Benefit was primarily defined in terms of less decisional conflict regarding treatment options. Furthermore, it was determined whether patients who used the decision aid were better informed about the disorder, less likely to be anxious, and be more satisfied in terms of their communication with the surgeon. Final treatment choice and health outcomes were also documented.
METHODS

Trial design
A six-centre, randomised clinical trial was conducted in the Netherlands (DECAID-trial; registered as NTR1524) comparing an additional decision aid versus regular information as provided by the surgeon regarding elective surgery and watchful waiting for asymptomatic abdominal aortic aneurysms. The study was approved by the local medical ethics review board of each participating centre. The trial was designed, conducted, and described according to the revised CONSORT statement. 9 "Intervention": decision aid in addition to regular information
The decision aid comprises an interactive computer program provided on a CD-ROM. It presents up-to-date, evidence-based information about abdominal aortic aneurysms and their treatment options; elective aneurysm surgery and watchful waiting, and the pros and cons of those treatment options, as is required by European law. 2 The decision aid patients with aneurysms of less than 5.5 cm were advised to agree with watchful waiting, in keeping with available evidence at that time. 10 For patients with aneurysms of at least 5.5 cm, the decision aid provided a comprehensive insight into the balance of benefit and harm of a surgical (open and endovascular) and a conservative approach, taking age, co-morbidity, and size of the aneurysm into account. The program also includes a number of questions that invite the patient to clarify his or her preferences. For example: "To what extent would you be anxious or worried about rupture if you do not get surgical treatment?". In the decision aid no advice towards a certain treatment option was given to patients with aneurysms of at least 5.5 cm. Finally, the decision to be considered by the patient was about whether to perform elective surgery or watchful waiting. This decision aid meets the quality criteria for patient decision support technologies developed by the International Patient Decision Aids Standards Collaboration. 7 
Participants
Eligible patients were identified between November 2008 and June 2011 at the outpatient clinic. Inclusion criteria were patients of at least 18 years of age, who were visiting the outpatient clinic for the first time with an asymptomatic abdominal aortic aneurysm diameter of at least 4.0 cm as confirmed by ultrasonography or CT scanning. Patients also had to understand Dutch well enough to be able to participate in the study. Exclusion criteria were any kind of end-stage disease resulting in estimation of life expectancy of less than a year, or lack of necessary mental capacity to provide informed consent.
Eligibility
During their first contact, the consulting surgeon briefly informed the patients and asked for their verbal consent to participate in the study. Patients received a brochure about the study to take home. If they agreed to participate, they provided written informed consent and returned the baseline questionnaire to the research centre in a pre-paid envelope.
Randomisation
Subsequently, computer-generated randomisation (ALEA v. 2.2, NKI-AVL, the Netherlands) was performed by the investigators after the informed consent form was received. Given that aneurysm size and operative risk may influence the extent of decisional conflict, minimisation was applied to ensure a well-balanced distribution of patients. In patients with an aneurysm diameter of less than 5.5 cm, surgery is generally not considered to be beneficial according to available evidence. 10e12 The Glasgow Aneurysm Score classifies patients into low versus high risk of postoperative complications based on the patient's age, preoperative renal function, cerebrovascular and cardiac events. 13 The minimisation algorithm therefore included: (1) aneurysm diameter either below 5.5 cm or at least 5.5 cm; and (2) Glasgow Aneurysm Score either below 81 or at least 81. Although more recent validation studies advocate other predictive models, 14, 15 the Glasgow Aneurysm Score was applied here as it guided treatment decision making and surgeons' communication with the patient at the time of the study.
Procedures
Patients in the control group received regular information. Patients allocated to the decision aid received regular information, but also came to the outpatient clinic within 3 weeks of randomisation. A research assistant provided the decision aid for one time viewing. She was present to ensure that the program functioned properly; she was not allowed to provide additional information or support. If participants were unable to come to the outpatient clinic, they were visited by the research assistant at home. All other aspects of care for aneurysm patients in both the decision aid and control groups (diagnostic work-up, watchful waiting, [endo] vascular procedures) were performed according to the Dutch national guideline on abdominal aortic aneurysm treatment. 16 No restrictions were made about who has to make the treatment decision, that is the decision aid was studied as an additional source of information in the care of abdominal aneurysm patients.
Patients and investigators could not be blinded after group assignment, a factor which is inherent to the decision aid and the design of the study. Surgeons and nurses involved in the outpatient care of the participants were blinded to the patient's allocation group, although patients were not prohibited from sharing their allocation with them.
Follow-up
Patients received questionnaires by mail 1, 4, and 10 months after randomisation.
Primary outcome. The primary outcome was decisional conflict as measured by the validated Decisional Conflict Scale after one month. 17, 18 This 16-item scale expresses the degree of uncertainty within an individual about which course of action to take. Scores range from 0 (none at all) to 100 (severe decisional conflict). The 1-month time interval was chosen because, by then, patients were supposed to have made their treatment decision and elective surgery would probably not have been performed yet. Decisional conflict assessment was repeated at 4 months and 10 months after the date of randomisation.
Secondary outcomes. Patient knowledge of the disorder and treatment options was assessed by means of 13 items of the Dutch multiple-choice Aneurysm Knowledge Questionnaire at baseline and after the 1-month follow-up. 19 The score ranges between 0 (no understanding at all) and 13 points (complete understanding). Levels of anxiety were measured at baseline and at the 1-month, 4-month, and 10-month follow-ups, using the validated Hospital Anxiety and Depression Scale. Employing the items which question anxiety on this scale, the anxiety score ranges from 0 to 21. 20 Patient satisfaction with respect to the conversation with the surgeon at the outpatient clinic was assessed by means of the Patient Satisfaction Questionnaire at baseline and after 1-month follow-up. The validated questionnaire consists of five visual analogue scales, anchored at 0 and 100. 21, 22 Physical quality of life was measured with the widely used and validated Medical Outcomes Study 12-Item Short-Form Health Survey at baseline and after all follow-up events. 23 The scale renders a score ranging from 0 to100 points.
The other outcomes were retrieved from medical records 10 months after the date of randomisation: final treatment choice, aneurysm rupture, possible date of surgery, and postoperative mortality, and major morbidity. Major morbidity was defined as postoperative complications interfering with everyday activities in the long term, such as re-operation in the event of bowel or peripheral ischemia, renal failure requiring dialysis, pulmonary embolus, stroke, and myocardial infarction requiring resuscitation. 24 
Sample size
To estimate the necessary group size, a previous study on a decision aid for benign prostatic hypertrophy patients was chosen because of the similarity of the study and the likely similarities of the sex and age distribution of the participants. 25 A pre-study power analysis showed that a group size of 85 would allow detection of a significant difference of 7.5 points on the 100-point Decisional Conflict Scale between groups one month after inclusion with a power of 90% and at a significance level of 0.05, assuming a mean decisional conflict score of 32.5 in patients assigned to the decision aid group and a standard deviation of 15. Allowing for attrition of 5% during the first month, it was planned to include a total of 178 asymptomatic abdominal aortic aneurysm patients.
Data collection and analysis
The total number of eligible patients was determined in retrospect by examining the medical records of all patients who had been documented with an abdominal aortic aneurysm-related code during the inclusion period.
The following information was collected from patients' medical records at baseline: aneurysm diameter, smoking status, hypertension, hypercholesterolemia, diabetes, stroke, transient ischemic attack, myocardial infarction, angina pectoris, heart failure, and chronic or acute kidney failure. At baseline, patients were also asked about their treatment preference, if any.
Exclusion of study participants with missing values on one or more items can cause biased results and decreases statistical efficiency. For this reason, missing values in our dataset were completed by multiple imputation analysis. This method uses all available data to impute the missing values based on the correlation between variables with missing values and all other variables. If one of the outcome measures of a patient had more than 25% missing values, that particular outcome measure of that patient was excluded from the analyses.
All analyses were made on an intention to treat basis. For group comparisons of continuous variables, analysis of covariance (ANCOVA) was used, using the baseline value as a covariate to reduce residual variance in comparisons and to correct for possible differences in the corresponding measure at baseline. For group comparisons of categorical variables, the chi-square test was used or the Fisher's exact test in the event of an expected count below 10. A p value less than .05 was considered to indicate a significant difference. SPSS for Windows version 19.0 was used (IBM SPSS, Armonk, NY, USA).
In terms of the primary outcome, two subgroup analyses were planned: one for patients with aneurysms larger than 5.5 cm, given that these patients were expected to experience high levels of decisional conflict and could therefore benefit more from the decision aid; and the second for patients with an aneurysm measuring less than 5.5 cm, given that they were expected to experience less decisional conflict because of clear-cut evidence to support performing watchful waiting at this stage.
RESULTS
Out of 1,072 patients documented with an abdominal aortic aneurysm-related code during the inclusion period, 722 appeared not to meet inclusion criteria. Another 172 patients were not randomised for the reasons shown in Fig. 1 . Eventually, 178 asymptomatic abdominal aortic aneurysm patients participated in the study. Patients included were predominantly male and on average just over 70 years of age with a mean aneurysm diameter of 5.4 cm ( Table 1) . At baseline, about half of the patients stated they would prefer elective surgical repair, about a third would prefer watchful waiting, and a minority were unsure.
Of the included patients, 176 (99%) actually received the regular information from the surgeon or additional viewing of the decision aid to which they were allocated (Fig. 1) . Outcomes at 1-month follow-up were available for 166 (93%). The proportion of values missing varied from 2% to 9% per outcome measure.
Decisional conflict scores had decreased in both randomisation arms at 1-month follow-up, but without a significant difference between the decision aid group and the control group (22 vs. 24, p ¼ .33) ( Table 2 ). After viewing the decision aid, patients had greater knowledge concerning their disorder and the available treatment options when compared with patients allocated to the control group (10.0 vs. 9.4; p ¼ .04) ( Table 2 ). Patient anxiety levels did not differ between the decision aid and control group at 1-month follow-up (4.4 vs. 5.0, p ¼ .73). All patients expressed being satisfied with the information and conversation with the surgeon at the outpatient clinic, with no differences between the groups (73 vs. 73, p ¼ .81). Physical quality of life scores did not differ between patients in the decision aid group and those in the control group (52 vs. 53, p ¼ .27). At 1-month follow-up, all patients had decided about treatment. The number of patients that chose elective aneurysm repair was similar in both arms: 39 in the decision aid group and 36 in the control group (p ¼ .84) ( Table 3) . Postoperative mortality, major morbidity, and rate of aneurysm rupture did not differ significantly between patients who had versus those who had not viewed the decision aid.
In the subgroup of patients with an aneurysm of 5.5 cm or more (Table 4) , decisional conflict scores did not differ significantly between randomisation arms (15 in decision aid group vs. 15 in control group, p ¼ .93). In patients with an aneurysm of below 5.5 cm, baseline decisional conflict levels appeared to be higher in contrast to baseline levels of the other patients included (Table 4) . At the 1-month follow-up, there was no statistically significant difference in decisional conflict levels between randomisation arms for patients with an aneurysm less than 5.5 cm (28 vs. 30, p ¼ . 19 ).
DISCUSSION
This study shows that a treatment decision aid provided to patients recently diagnosed with an abdominal aortic aneurysm did not significantly reduce decisional conflict when used in addition to regular patient-surgeon communication. Patients receiving the decision aid showed greater knowledge of their disorder and available treatment options without being more anxious. However, the decision aid did not increase patient satisfaction or health outcomes.
As opposed to previous reviews on decision aids in surgery, 6, 26 in the present study no significant reduction was found in patients' decisional conflict. Moreover, decisional conflict levels appeared to be lower than anticipated. This may be because elective aneurysm surgery differs from other types of surgery as patients are asymptomatic at the time of making the decision while they have to consider the risk of fatal aneurysm rupture. Therefore, it is a commonly accepted practice to extensively inform patients about the surgical procedure, potential complications, prognosis, and alternative treatment options. The unexpected finding that patients with a small aneurysm experienced more decisional conflict could be explained as these patients tend to have shorter consultations with their surgeon. 4 Moreover, patients with small aneurysms might not relish the idea of watchful waiting, that is postponing elective surgery while running the risk of rupture between follow-up visits.
The present findings of increased patient knowledge with unaltered anxiety levels, satisfaction, or health outcomes are in keeping with previous studies on other decision aids. 6, 26 One could doubt the relevance of the rather marginal increase in knowledge, although in a previous pilot study patients felt better informed and claimed that the decision aid adds value in the decision making process about abdominal aortic aneurysms. 8 Moreover, the size of the effect does approach that of a recent systematic review on other decision aids in surgery. 6 There are two limitations of this study. First, a considerable number of patients could not be included, were not asked to participate, or declined to participate. Based on the motives recorded for declining trial participation, there is no reason to assume that these patients differ systematically from the study participants; however, selection bias may have occurred in patients that were not included. Second, the fact that both patients and surgeons were aware of the aim and subject of the study and could not be blinded to the allocation may have introduced performance bias in terms of altered communication styles. It is possible that surgeons in the contributing centres offered more than average information to their patients.
Future research should focus on identifying specific subgroups of patients who may derive more benefit from the introduction of the decision aid. In this study, a greater decline in decisional conflict was observed in patients with a small aneurysm, but the study was not powered for evaluating such effects with sufficient precision. Another group of patients who may benefit more from decision aids are those expressing the need for more explicit information in the first consultation with their surgeon or expressing high decisional conflict scores, thereby overlooking the full range of consequences of treatment options. 27 The actual use of the decision aid in daily clinical practice may pose some challenges. 28 It is up to the surgeon to first acknowledge the importance of sharing this treatment decision with patients. When considering the use of the decision aid, the surgeon has to evaluate whether the patient will understand the information being provided. 29, 30 Some patients may not understand enough about their health and their condition to be able to make evidence-guided decisions, but such patients may be hard to identify. 31 Then, some physicians in other medical specialties reported a reluctance to use decision aids as their use would prolong physician-patient communication. 32, 33 Yet, one could argue that when patients are informed about their condition and treatment options beforehand, actual consultation times might be reduced and interaction optimised, as this time can be focused on resolving remaining areas of uncertainty.
In conclusion, surgeons in clinical practice face the challenge of sharing aneurysm treatment decisions with patients. This study shows that it can be safe to use a decision aid in addition to regular surgeon patient communication for this purpose, as use of the decision aid did not increase anxiety, nor did it affect health outcomes. In this way, patients can be provided with complete evidence-based information about their disease and the available treatment options, while their preferences are being elicited as well, irrespective of the hospital or surgeon they visited. Nevertheless, the effects of the decision aid in terms of reducing decisional conflict or improving satisfaction are, at best, very limited.
